Background
Methods
Virucidal products tested
Propagation of the test virus
MVA
EBOV
Determination of cytotoxicity
Inactivation assay using quantitative suspension test for MVA
Inactivation assay using large volume plating (LVP) method for verification of concentration-contact time values with EBOV
Statistical methods
If no virus is observed
If a low number of viruses is detected
Results
Determination of the PVP-I kinetics with low and high protein load using the new European test virus for virucidal efficacy against enveloped viruses (MVA)
Test product | Dilution | Log10 reduction factor (95 % confidence interval, where applicable) | |||||
---|---|---|---|---|---|---|---|
Clean conditions | Dirty conditions | ||||||
Application time | Application time | ||||||
15 s | 30 s | 60 s | 15 s | 30 s | 60 s | ||
PVP-I solution (10 g/L available iodine) | Undiluted (10 g/L) |
≥4.00
|
≥4.00
|
≥4.00
|
≥4.17
|
≥4.17
|
≥4.17
|
1:10 (1 g/L) |
≥5.67
|
≥5.67
|
≥5.67
|
≥5.50
|
≥5.50
|
≥5.50
| |
1:100 (0.1 g/L) | 4.33 (±0.63) | 5.67 (±0.60) |
≥6.33
| 2.83 (±0.54) | 3.50 (±0.65) | 3.50 (±0.54) | |
PVP-I surgical scrub (7.5 g/L available iodine) | Undiluted (7.5 g/L) |
≥4.00
|
≥4.00
|
≥4.00
|
≥4.17
|
≥4.17
|
≥4.17
|
1:10 (0.75 g/L) |
≥5.50
|
≥5.50
|
≥5.50
|
≥5.67
|
≥5.67
|
≥5.67
| |
1:100 (0.075 g/L) | 3.83 (±0.65) | 4.17 (±0.58) | 4.50 (±0.58) | 1.00 (±0.70) | 1.67 (±0.70) | 1.83 (±0.71) | |
PVP-I skin cleanser (4 g/L available iodine) | Undiluted (4 g/L) |
≥4.17
|
≥4.17
|
≥4.17
|
≥4.00
|
≥4.00
|
≥4.00
|
1:10 (0.4 g/L) | 4.50 (±0.54) |
≥4.67
|
≥4.67
| 4.33 (±0.56) |
≥4.50
|
≥4.50
| |
1:100 (0.04 g/L) | 3.33 (±0.56) | 3.67 (±0.47) | 3.67 (±0.47) | 0.33 (±0.56) | 1.00 (±0.63) | 1.00 (±0.63) | |
PVP-I/alcohol solution (3.2 g/L available iodine) | Undiluted (3.2 g/L) |
≥5.67
|
≥5.67
|
≥5.67
|
≥5.67
|
≥5.67
|
≥5.67
|
1:10 (0.32 g/L) | 5.50 (±0.54) | 6.33 (±0.56) | 6.33 (±0.56) | 3.00 (±0.63) | 4.00 (±0.47) | 4.83 (±0.33) | |
1:100 (0.032 g/L) | 1.83 (±0.54) | 2.00 (±0.60) | 2.50 (±0.54) | −0.17 (±0.68) | 0.00 (±0.60) | 0.17 (±0.54) |